Selected research
Industry Research
Irreversible Electroporation (IRE) Industry Research Report 2026
Market perspective
The global Irreversible Electroporation (IRE) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Irreversible Electroporation (IRE) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Irreversible Electroporation (IRE) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Irreversible Electroporation (IRE) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Irreversible Electroporation (IRE) include Acutus Medical, AngioDynamics, Kardium, Pulse Biosciences, Boston Scientific, Hangzhou Nuomao Medical Technology, Medtronic, Johnson & Johnson and Surgnova, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Irreversible Electroporation (IRE) market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Irreversible Electroporation (IRE) Market by Company
Acutus Medical
AngioDynamics
Kardium
Pulse Biosciences
Boston Scientific
Hangzhou Nuomao Medical Technology
Medtronic
Johnson & Johnson
Surgnova
Nortion
Shineyo Medical
Tianjin Intelligent Health Medical
Irreversible Electroporation (IRE) Segment by Type
Pulsed Field Ablation System
Steep Pulse Ablation System (NanoKnife)
Irreversible Electroporation (IRE) Segment by Application
Tumors
Cardiac Diseases
Irreversible Electroporation (IRE) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Irreversible Electroporation (IRE) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Irreversible Electroporation (IRE) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Irreversible Electroporation (IRE).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Irreversible Electroporation (IRE) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Irreversible Electroporation (IRE) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Irreversible Electroporation (IRE) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pulsed Field Ablation System
- Steep Pulse Ablation System (NanoKnife)
Applications
- Tumors
- Cardiac Diseases
Companies covered
- Acutus Medical
- AngioDynamics
- Kardium
- Pulse Biosciences
- Boston Scientific
- Hangzhou Nuomao Medical Technology
- Medtronic
- Johnson & Johnson
- Surgnova
- Nortion
- Shineyo Medical
- Tianjin Intelligent Health Medical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Irreversible Electroporation (IRE) Market Size (2021-2032)
- 2.2.2 Global Irreversible Electroporation (IRE) Sales (2021-2032)
- 2.2.3 Global Irreversible Electroporation (IRE) Market Average Price (2021-2032)
- 2.3 Irreversible Electroporation (IRE) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Pulsed Field Ablation System
- 2.3.3 Steep Pulse Ablation System (NanoKnife)
- 2.4 Irreversible Electroporation (IRE) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Tumors
- 2.4.3 Cardiac Diseases
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Irreversible Electroporation (IRE) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Irreversible Electroporation (IRE) Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Irreversible Electroporation (IRE) Revenue of Manufacturers (2021-2026)
- 3.4 Global Irreversible Electroporation (IRE) Average Price by Manufacturers (2021-2026)
- 3.5 Global Irreversible Electroporation (IRE) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Irreversible Electroporation (IRE), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Irreversible Electroporation (IRE), Product Type & Application
- 3.8 Global Manufacturers of Irreversible Electroporation (IRE), Established Date
- 3.9 Global Irreversible Electroporation (IRE) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Acutus Medical
- 4.1.1 Acutus Medical Company Information
- 4.1.2 Acutus Medical Business Overview
- 4.1.3 Acutus Medical Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Acutus Medical Irreversible Electroporation (IRE) Product Portfolio
- 4.1.5 Acutus Medical Recent Developments
- 4.2 AngioDynamics
- 4.2.1 AngioDynamics Company Information
- 4.2.2 AngioDynamics Business Overview
- 4.2.3 AngioDynamics Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 AngioDynamics Irreversible Electroporation (IRE) Product Portfolio
- 4.2.5 AngioDynamics Recent Developments
- 4.3 Kardium
- 4.3.1 Kardium Company Information
- 4.3.2 Kardium Business Overview
- 4.3.3 Kardium Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Kardium Irreversible Electroporation (IRE) Product Portfolio
- 4.3.5 Kardium Recent Developments
- 4.4 Pulse Biosciences
- 4.4.1 Pulse Biosciences Company Information
- 4.4.2 Pulse Biosciences Business Overview
- 4.4.3 Pulse Biosciences Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pulse Biosciences Irreversible Electroporation (IRE) Product Portfolio
- 4.4.5 Pulse Biosciences Recent Developments
- 4.5 Boston Scientific
- 4.5.1 Boston Scientific Company Information
- 4.5.2 Boston Scientific Business Overview
- 4.5.3 Boston Scientific Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Boston Scientific Irreversible Electroporation (IRE) Product Portfolio
- 4.5.5 Boston Scientific Recent Developments
- 4.6 Hangzhou Nuomao Medical Technology
- 4.6.1 Hangzhou Nuomao Medical Technology Company Information
- 4.6.2 Hangzhou Nuomao Medical Technology Business Overview
- 4.6.3 Hangzhou Nuomao Medical Technology Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Hangzhou Nuomao Medical Technology Irreversible Electroporation (IRE) Product Portfolio
- 4.6.5 Hangzhou Nuomao Medical Technology Recent Developments
- 4.7 Medtronic
- 4.7.1 Medtronic Company Information
- 4.7.2 Medtronic Business Overview
- 4.7.3 Medtronic Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Medtronic Irreversible Electroporation (IRE) Product Portfolio
- 4.7.5 Medtronic Recent Developments
- 4.8 Johnson & Johnson
- 4.8.1 Johnson & Johnson Company Information
- 4.8.2 Johnson & Johnson Business Overview
- 4.8.3 Johnson & Johnson Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Johnson & Johnson Irreversible Electroporation (IRE) Product Portfolio
- 4.8.5 Johnson & Johnson Recent Developments
- 4.9 Surgnova
- 4.9.1 Surgnova Company Information
- 4.9.2 Surgnova Business Overview
- 4.9.3 Surgnova Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Surgnova Irreversible Electroporation (IRE) Product Portfolio
- 4.9.5 Surgnova Recent Developments
- 4.10 Nortion
- 4.10.1 Nortion Company Information
- 4.10.2 Nortion Business Overview
- 4.10.3 Nortion Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Nortion Irreversible Electroporation (IRE) Product Portfolio
- 4.10.5 Nortion Recent Developments
- 4.11 Shineyo Medical
- 4.11.1 Shineyo Medical Company Information
- 4.11.2 Shineyo Medical Business Overview
- 4.11.3 Shineyo Medical Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Shineyo Medical Irreversible Electroporation (IRE) Product Portfolio
- 4.11.5 Shineyo Medical Recent Developments
- 4.12 Tianjin Intelligent Health Medical
- 4.12.1 Tianjin Intelligent Health Medical Company Information
- 4.12.2 Tianjin Intelligent Health Medical Business Overview
- 4.12.3 Tianjin Intelligent Health Medical Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Tianjin Intelligent Health Medical Irreversible Electroporation (IRE) Product Portfolio
- 4.12.5 Tianjin Intelligent Health Medical Recent Developments
5 Global Irreversible Electroporation (IRE) Market Scenario by Region
- 5.1 Global Irreversible Electroporation (IRE) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Irreversible Electroporation (IRE) Sales by Region: 2021-2032
- 5.2.1 Global Irreversible Electroporation (IRE) Sales by Region: 2021-2026
- 5.2.2 Global Irreversible Electroporation (IRE) Sales by Region: 2027-2032
- 5.3 Global Irreversible Electroporation (IRE) Revenue by Region: 2021-2032
- 5.3.1 Global Irreversible Electroporation (IRE) Revenue by Region: 2021-2026
- 5.3.2 Global Irreversible Electroporation (IRE) Revenue by Region: 2027-2032
- 5.4 North America Irreversible Electroporation (IRE) Market Facts & Figures by Country
- 5.4.1 North America Irreversible Electroporation (IRE) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Irreversible Electroporation (IRE) Sales by Country (2021-2032)
- 5.4.3 North America Irreversible Electroporation (IRE) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Irreversible Electroporation (IRE) Market Facts & Figures by Country
- 5.5.1 Europe Irreversible Electroporation (IRE) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Irreversible Electroporation (IRE) Sales by Country (2021-2032)
- 5.5.3 Europe Irreversible Electroporation (IRE) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Irreversible Electroporation (IRE) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Irreversible Electroporation (IRE) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Irreversible Electroporation (IRE) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Irreversible Electroporation (IRE) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Irreversible Electroporation (IRE) Market Facts & Figures by Country
- 5.7.1 South America Irreversible Electroporation (IRE) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Irreversible Electroporation (IRE) Sales by Country (2021-2032)
- 5.7.3 South America Irreversible Electroporation (IRE) Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Irreversible Electroporation (IRE) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Irreversible Electroporation (IRE) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Irreversible Electroporation (IRE) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Irreversible Electroporation (IRE) Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Irreversible Electroporation (IRE) Sales by Type (2021-2032)
- 6.1.1 Global Irreversible Electroporation (IRE) Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Irreversible Electroporation (IRE) Sales Market Share by Type (2021-2032)
- 6.2 Global Irreversible Electroporation (IRE) Revenue by Type (2021-2032)
- 6.2.1 Global Irreversible Electroporation (IRE) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Irreversible Electroporation (IRE) Revenue Market Share by Type (2021-2032)
- 6.3 Global Irreversible Electroporation (IRE) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Irreversible Electroporation (IRE) Sales by Application (2021-2032)
- 7.1.1 Global Irreversible Electroporation (IRE) Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Irreversible Electroporation (IRE) Sales Market Share by Application (2021-2032)
- 7.2 Global Irreversible Electroporation (IRE) Revenue by Application (2021-2032)
- 7.2.1 Global Irreversible Electroporation (IRE) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Irreversible Electroporation (IRE) Revenue Market Share by Application (2021-2032)
- 7.3 Global Irreversible Electroporation (IRE) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Irreversible Electroporation (IRE) Value Chain Analysis
- 8.1.1 Irreversible Electroporation (IRE) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Irreversible Electroporation (IRE) Production Mode & Process
- 8.2 Irreversible Electroporation (IRE) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Irreversible Electroporation (IRE) Distributors
- 8.2.3 Irreversible Electroporation (IRE) Customers
9 Global Irreversible Electroporation (IRE) Analyzing Market Dynamics
- 9.1 Irreversible Electroporation (IRE) Industry Trends
- 9.2 Irreversible Electroporation (IRE) Industry Drivers
- 9.3 Irreversible Electroporation (IRE) Industry Opportunities and Challenges
- 9.4 Irreversible Electroporation (IRE) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst